Holen Sie sich die Stockscreener-App
0.4882
2.36%
-0.0118
Finanzdaten der Outlook Therapeutics Inc-Aktie (OTLK)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Cost Of Revenue |
88.64%
0.017
|
0.1493 | 0.0296 | 0.9165 | 0.4398 |
| Gross Profit |
62.24%
-0.00827
|
-0.0219 | -1.2375 | -1.0083 | 1.0655 |
Selling, General, and Administrative
|
20.56%
7.5508
|
9.5046 | - | - | - |
| Depreciation and Amortization |
54.66%
0.0138
|
0.0304 | 0.0301 | 0.0297 | 0.0294 |
| Operating Income/Loss |
22.93%
-10.81
|
-14.03 | -13.48 | -17.31 | -15.75 |
| Net Interest Income/Expense |
133.33%
0.000007
|
0.000003 | - | -0.2642 | -0.0494 |
| Income/Loss From Equity Method Investments |
9.10%
-0.041
|
-0.0451 | -0.0386 | -0.0404 | -0.0309 |
| Income/Loss From Continuing Operations Before Tax |
356.30%
-20.32
|
-4.4531 | -23.06 | -14.85 | -20.15 |
|
Net Income/Loss
|
356.30%
-20.32
|
-4.4531 | -23.06 | -13.29 | -20.15 |
| Basic Average Shares |
67.09%
136.74
|
81.84 | 60.21 | 4.1321 | 36.96 |
| Diluted Average Shares |
67.09%
136.74
|
81.84 | 60.21 | 4.1321 | 36.96 |
| Basic Earnings Per Share |
200.00%
-0.15
|
-0.05 | -0.38 | -0.19 | -0.55 |
| Diluted Earnings Per Share |
200.00%
-0.15
|
-0.05 | -0.38 | -0.19 | -0.55 |
4.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):